News

News
Partner news

Mestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease

Read full story
Partner news

L'engagement de Janssen France dans l'IA et la génomique

Read full story
Partner news

resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology

Read full story
Partner news

ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes

Read full story
Partner news

Inivata Announces Strategic Collaboration and Investment from NeoGenomics

Read full story
Partner news

Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics

Read full story
Partner news

Cala Health Raises $50 Million Series C Funding

Read full story
Partner news

TU Dresden announces collaboration with Janssen to advance next-generation nuclease-free gene editing platform

Read full story
Partner news

Zebra Medical Vision Receives FDA Approval for World's First AI Chest X-ray Triage Product

Read full story
JNJ Press releases

GCV Powerlist 2018: #5 Tom Heyman

Read full story
Partner news

GRAIL Announces $300 Million Raised in Oversubscribed Series C Financing

Read full story
JNJ Press releases

Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimen

Read full story
Partner news

BRIEF-Provention Bio Files For IPO Of Up To $50 Million

Read full story
Partner news

Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders

Read full story
JNJ Press releases

Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimen

Read full story